Coronary Artery Calcification: From Mechanism to Molecular Imaging

JACC: Cardiovascular Imaging

Volumn 10, Issue 5, 2017, Pages 582-593

  Nakahara, Takehiro ^a,b   Dweck, Marc R ^a,c   Narula, Navneet ^d   Pisapia, David ^d   Narula, Jagat ^a   Strauss, H William ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

calcification; chondrogenic osteogenic differentiation; imaging; matrix vesicle; vulnerable plaques

Indexed keywords

FETUIN A; KLOTHO PROTEIN; OSTEOCALCIN; OSTEOPONTIN; OSTEOPROTEGERIN; PYROPHOSPHATE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CORONARY ARTERY CALCIFICATION; HUMAN; INFLAMMATION; MOLECULAR IMAGING; NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; ANIMAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; FIBROSIS; METABOLISM; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RISK FACTOR; RUPTURE; SIGNAL TRANSDUCTION;

ANIMALS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FIBROSIS; HUMANS; MOLECULAR IMAGING; NECROSIS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; RUPTURE, SPONTANEOUS; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

EID: 85018385783     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2017.03.005     Document Type: Review

References (137)

1. 1 Virchow, R., Cellular Pathology: As Based Upon Physiological and Pathological Histology. 1863, Dover Publications, New York, NY, 404–408 Unabridged reprinting 1971.
2. 2 Tanimura, A., McGregor, D.H., Anderson H, C., Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med 172 (1983), 173–177.
3. 3 Jorgens, J., Blank, N., Wilcox, W.A., The cinefluorographic detection and recording of calcifications within the heart: results of 803 examinations. Radiology 74 (1960), 550–554.
4. 4 Oliver, M.F., Samuel, E., Morley, P., Young, G.B., Kapur, P.L., Detection of coronary-artery calcification during life. Lancet 1 (1964), 891–895.
5. 5 Agatston, A.S., Janowitz, W.R., Hildner, F.J., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15 (1990), 827–832.
6. 6 Mark, D.B., Berman, D.S., Budoff, M.J., et al. ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55 (2010), 2663–2699.
7. 7 Maurovich-Horvat, P., Ferencik, M., Voros, S., et al. Comprehensive plaque assessment by coronary CT angiography. Nature Rev Cardiol 11 (2014), 390–402.
8. 8 New, S.E., Aikawa, E., Role of extracellular vesicles in de novo mineralization: an additional novel mechanism of cardiovascular calcification. Arterioscler Thromb Vasc Biol 33 (2013), 1753–1758.
9. 9 Bailey, G., Meadows, J., Morrison, A.R., Imaging atherosclerotic plaque calcification: translating biology. Curr Atheroscler Rep, 18, 2016, 51.
10. 10 Kapustin, A.N., Chatrou, M.L., Drozdov, I., et al. Vascular smooth muscle cell calcification is mediated by regulated exosome secretion. Circ Res 116 (2015), 1312–1323.
11. 11 New, S.E., Goettsch, C., Aikawa, M., et al. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcification in atherosclerotic plaques. Circ Res 113 (2013), 72–77.
12. 12 Tanimura, A., McGregor, D.H., Anderson, H.C., Calcification in atherosclerosis. I. Human studies. J Exp Pathol 2 (1986), 261–273.
13. 13 Aikawa, E., Nahrendorf, M., Figueiredo, J.L., et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation 116 (2007), 2841–2850.
14. 14 Shanahan, C.M., Cary, N.R., Metcalfe, J.C., Weissberg, P.L., High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93 (1994), 2393–2402.
15. 15 Bobryshev, Y.V., Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: implications for diffuse intimal calcification. J Pathol 205 (2005), 641–650.
16. 16 Bro, S., Borup, R., Andersen, C.B., Moeller, F., et al. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 26 (2006), 570–575.
17. 17 Schmidt, H.H., Hill, S., Makariou, E.V., et al. Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 77 (1996), 575–580.
18. 18 Schmermund, A., Baumgart, D., Mohlenkamp, S., et al. Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: an electron-beam CT study. Arterioscler Thromb Vasc Biol 21 (2001), 421–426.
19. 19 Bild, D.E., Folsom, A.R., Lowe, L.P., et al. Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 21 (2001), 852–857.
20. 20 Pohle, K., Maffert, R., Ropers, D., et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation 104 (2001), 1927–1932.
21. 21 Chen, N.X., Duan, D., O'Neill, K.D., Moe, S.M., High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21 (2006), 3435–3442.
22. 22 Al-Aly, Z., Shao, J.S., Lai, C.F., et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice. Arterioscler Thromb Vasc Biol 27 (2007), 2589–2596.
23. 23 Luo, G., Ducy, P., McKee, M.D., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (1997), 78–81.
24. 24 Neven, E., Dauwe, S., De Broe, M.E., et al. Endochondral bone formation is involved in media calcification in rats and in men. Kidney Int 72 (2007), 574–581.
25. 25 Neven, E., Persy, V., Dauwe, S., et al. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol 30 (2010), 1741–1750.
26. 26 Neven, E., D'Haese, P.C., Vascular calcification in chronic renal failure: what have we learned from animal studies?. Circ Res 108 (2011), 249–264.
27. 27 Nakashima, K., de Crombrugghe, B., Transcriptional mechanisms in osteoblast differentiation and bone formation. Trends Genet 19 (2003), 458–466.
28. 28 Day, T.F., Yang, Y., Wnt and hedgehog signaling pathways in bone development. J Bone Joint Surg Am 90:Suppl 1 (2008), 19–24.
29. 29 Bostrom, K., Watson, K.E., Horn, S., et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91 (1993), 1800–1809.
30. 30 Canfield, A.E., Sutton, A.B., Hoyland, J.A., Schor, A.M., Association of thrombospondin-1 with osteogenic differentiation of retinal pericytes in vitro. J Cell Sci 109:Pt 2 (1996), 343–353.
31. 31 Proudfoot, D., Skepper, J.N., Shanahan, C.M., Weissberg, P.L., Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 18 (1998), 379–388.
32. 32 Demer, L.L., Tintut, Y., Vascular calcification: pathobiology of a multifaceted disease. Circulation 117 (2008), 2938–2948.
33. 33 Speer, M.Y., Yang, H.Y., Brabb, T., et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 104 (2009), 733–741.
34. 34 Doehring, L.C., Heeger, C., Aherrahrou, Z., et al. Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocyte-like cells in atherosclerotic intimal calcification. Am J Pathol 177 (2010), 473–480.
35. 35 Williams, K.J., Tabas, I., The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 15 (1995), 551–561.
36. 36 Tabas, I., Williams, K.J., Boren, J., Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116 (2007), 1832–1844.
37. 37 Nakashima, Y., Wight, T.N., Sueishi, K., Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc Res 79 (2008), 14–23.
38. 38 Tabas, I., Garcia-Cardena, G., Owens, G.K., Recent insights into the cellular biology of atherosclerosis. J Cell Biol 209 (2015), 13–22.
39. 39 Ohtsuki, K., Hayase, M., Akashi, K., Kopiwoda, S., Strauss, H.W., Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 104 (2001), 203–208.
40. 40 Mallat, Z., Tedgui, A., Apoptosis in the vasculature: mechanisms and functional importance. Br J Pharmacol 130 (2000), 947–962.
41. 41 Libby, P., Tabas, I., Fredman, G., Fisher, E.A., Inflammation and its resolution as determinants of acute coronary syndromes. Circ Res 114 (2014), 1867–1879.
42. 42 Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., Kroemer, G., Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 11 (2010), 700–714.
43. 43 Karunakaran, D., Geoffrion, M., Wei, L., et al. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Sci Adv, 2, 2016, e1600224.
44. 44 Kolodgie, F.D., Narula, J., Burke, A.P., et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol 157 (2000), 1259–1268.
45. 45 Van Vre, E.A., Ait-Oufella, H., Tedgui, A., Mallat, Z., Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler Thromb Vasc Biol 32 (2012), 887–893.
46. 46 Burke, A.P., Farb, A., Malcom, G.T., et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336 (1997), 1276–1282.
47. 47 Kolodgie, F.D., Gold, H.K., Burke, A.P., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 349 (2003), 2316–2325.
48. 48 Moreno, P.R., Purushothaman, K.R., Fuster, V., et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110 (2004), 2032–2038.
49. 49 Virmani, R., Kolodgie, F.D., Burke, A.P., et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25 (2005), 2054–2061.
50. 50 Virmani, R., Burke, A.P., Farb, A., Kolodgie, F.D., Pathology of the vulnerable plaque. J Am Coll Cardiol 47 (2006), C13–C18.
51. 51 Michel, J.B., Virmani, R., Arbustini, E., Pasterkamp, G., Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 32 (2011), 1977–1985 1985a, 1985b, 1985c.
52. 52 Shanahan, C.M., Inflammation ushers in calcification: a cycle of damage and protection?. Circulation 116 (2007), 2782–2785.
53. 53 Lomashvili, K.A., Cobbs, S., Hennigar, R.A., et al. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 15 (2004), 1392–1401.
54. 54 Otsuka, F., Sakakura, K., Yahagi, K., et al. Has our understanding of calcification in human coronary atherosclerosis progressed?. Arterioscler Thromb Vasc Biol 34 (2014), 724–736.
55. 55 Pugliese, G., Iacobini, C., Blasetti Fantauzzi, C., Menini, S., The dark and bright side of atherosclerotic calcification. Atherosclerosis 238 (2015), 220–230.
56. 56 Hutcheson, J.D., Goettsch, C., Bertazzo, S., et al. Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques. Nat Mater 15 (2016), 335–343.
57. 57 Anderson, H.C., Mechanisms of pathologic calcification. Rheum Dis Clin North Am 14 (1988), 303–319.
58. 58 Bobryshev, Y.V., Killingsworth, M.C., Lord, R.S., Grabs, A.J., Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture. J Cell Mol Med 12 (2008), 2073–2082.
59. 59 Kim, K.M., Calcification of matrix vesicles in human aortic valve and aortic media. Fed Proc 35 (1976), 156–162.
60. 60 Kapustin, A.N., Davies, J.D., Reynolds, J.L., et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res 109 (2011), e1–e12.
61. 61 Anderson, H.C., Molecular biology of matrix vesicles. Clin Orthop Relat Res, 1995, 266–280.
62. 62 Chen, N.X., O'Neill, K.D., Chen, X., Moe, S.M., Annexin-mediated matrix vesicle calcification in vascular smooth muscle cells. J Bone Miner Res 23 (2008), 1798–1805.
63. 63 Warner, G.P., Hubbard, H.L., Lloyd, G.C., Wuthier, R.E., 32Pi- and 45Ca-metabolism by matrix vesicle-enriched microsomes prepared from chicken epiphyseal cartilage by isosmotic Percoll density-gradient fractionation. Calcif Tissue Int 35 (1983), 327–338.
64. 64 Nancollas, G.H., LoRe, M., Perez, L., et al. Mineral phases of calcium phosphate. Anat Rec 224 (1989), 234–241.
65. 65 Leszczynska, A., O'Doherty, A., Farrell, E., et al. Differentiation of vascular stem cells contributes to ectopic calcification of atherosclerotic plaque. Stem Cells 34 (2016), 913–923.
66. 66 Neven, E., De Schutter, T.M., De Broe, M.E., D'Haese, P.C., Cell biological and physicochemical aspects of arterial calcification. Kidney Int 79 (2011), 1166–1177.
67. 67 Reynolds, J.L., Skepper, J.N., McNair, R., et al. Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol 16 (2005), 2920–2930.
68. 68 Proudfoot, D., Davies, J.D., Skepper, J.N., et al. Acetylated low-density lipoprotein stimulates human vascular smooth muscle cell calcification by promoting osteoblastic differentiation and inhibiting phagocytosis. Circulation 106 (2002), 3044–3050.
69. 69 Mantovani, A., Sica, A., Sozzani, S., et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25 (2004), 677–686.
70. 70 Hansson, G.K., Robertson, A.K., Soderberg-Naucler, C., Inflammation and atherosclerosis. Annu Rev Pathol 1 (2006), 297–329.
71. 71 Tabas, I., Bornfeldt, K.E., Macrophage phenotype and function in different stages of atherosclerosis. Circ Res 118 (2016), 653–667.
72. 72 Goodman, W.G., London, G., Amann, K., et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis 43 (2004), 572–579.
73. 73 Wallin, R., Schurgers, L., Wajih, N., Effects of the blood coagulation vitamin K as an inhibitor of arterial calcification. Thromb Res 122 (2008), 411–417.
74. 74 Bostrom, K., Tsao, D., Shen, S., et al. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276 (2001), 14044–14052.
75. 75 Zebboudj, A.F., Imura, M., Bostrom, K., Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 277 (2002), 4388–4394.
76. 76 Schurgers, L.J., Joosen, I.A., Laufer, E.M., et al. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PloS One, 7, 2012, e43229.
77. 77 Kruger, T., Oelenberg, S., Kaesler, N., et al. Warfarin induces cardiovascular damage in mice. Arterioscler Thromb Vasc Biol 33 (2013), 2618–2624.
78. 78 Fleisch, H., Russell, R.G., Straumann, F., Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212 (1966), 901–903.
79. 79 Schibler, D., Russell, R.G., Fleisch, H., Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. Clin Sci 35 (1968), 363–372.
80. 80 O'Neill, W.C., Lomashvili, K.A., Malluche, H.H., et al. Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int 79 (2011), 512–517.
81. 81 Jahnen-Dechent, W., Heiss, A., Schäfer, C., Ketteler, M., Fetuin-A regulation of calcified matrix metabolism. Circ Res 108 (2011), 1494–1509.
82. 82 Jono, S., Peinado, C., Giachelli, C.M., Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 275 (2000), 20197–20203.
83. 83 Speer, M.Y., McKee, M.D., Guldberg, R.E., et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 196 (2002), 1047–1055.
84. 84 Hu, M.C., Shi, M., Zhang, J., et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22 (2011), 124–136.
85. 85 Kuro-o, M., Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol 9 (2013), 650–660.
86. 86 Evrard, S., Delanaye, P., Kamel, S., et al. Vascular calcification: from pathophysiology to biomarkers. Clin Chim Acta 438 (2015), 401–414.
87. 87 Sandberg, W.J., Yndestad, A., Oie, E., et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol 26 (2006), 857–863.
88. 88 Morony, S., Tintut, Y., Zhang, Z., et al. Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in LDLR(-/-) mice. Circulation 117 (2008), 411–420.
89. 89 Price, P.A., June, H.H., Buckley, J.R., Williamson, M.K., Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 21 (2001), 1610–1616.
90. 90 Dhore, C.R., Cleutjens, J.P., Lutgens, E., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21 (2001), 1998–2003.
91. 91 Burke, A.P., Taylor, A., Farb, A., et al. Coronary calcification: insights from sudden coronary death victims. Z Kardiol 89:Suppl 2 (2000), 49–53.
92. 92 Roijers, R.B., Debernardi, N., Cleutjens, J.P., et al. Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries. Am J Pathol 178 (2011), 2879–2887.
93. 93 Kockx, M.M., De Meyer, G.R., Muhring, J., et al. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation 97 (1998), 2307–2315.
94. 94 Kelly-Arnold, A., Maldonado, N., Laudier, D., et al. Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries. Proc Natl Acad Sci U S A 110 (2013), 10741–10746.
95. 95 Vengrenyuk, Y., Carlier, S., Xanthos, S., et al. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps. Proc Natl Acad Sci U S A 103 (2006), 14678–14683.
96. 96 Kristanto, W., van Ooijen, P.M., Groen, J.M., et al. Small calcified coronary atherosclerotic plaque simulation model: minimal size and attenuation detectable by 64-MDCT and MicroCT. Int J Cardiovasc Imaging 28 (2012), 843–853.
97. 97 Naghavi, M., Libby, P., Falk, E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108 (2003), 1664–1672.
98. 98 Sangiorgi, G., Rumberger, J.A., Severson, A., et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31 (1998), 126–133.
99. 99 Wykrzykowska, J.J., Mintz, G.S., Garcia-Garcia, H.M., et al. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes. J Am Coll Cardiol Img 5 (2012), S10–S18.
100. 100 Burke, A.P., Kolodgie, F.D., Farb, A., et al. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 105 (2002), 297–303.
101. 101 Motoyama, S., Kondo, T., Sarai, M., et al. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 50 (2007), 319–326.
102. 102 Wilson, P.W., D'Agostino, R.B., Levy, D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998), 1837–1847.
103. 103 Detrano, R., Guerci, A.D., Carr, J.J., et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358 (2008), 1336–1345.
104. 104 Elias-Smale, S.E., Proenca, R.V., Koller, M.T., et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol 56 (2010), 1407–1414.
105. 105 Polonsky, T.S., McClelland, R.L., Jorgensen, N.W., et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303 (2010), 1610–1616.
106. 106 Criqui, M.H., Denenberg, J.O., McClelland, R.L., et al. Abdominal aortic calcium, coronary artery calcium, and cardiovascular morbidity and mortality in the Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 34 (2014), 1574–1579.
107. 107 Cox, A.J., Hsu, F.C., Agarwal, S., et al. Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study. Cardiovasc Diabetol, 13, 2014, 160.
108. 108 Allison, M.A., Hsi, S., Wassel, C.L., et al. Calcified atherosclerosis in different vascular beds and the risk of mortality. Arterioscler Thromb Vasc Biol 32 (2012), 140–146.
109. 109 Greenland, P., Alpert, J.S., Beller, G.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 122 (2010), 2748–2764.
110. 110 Nicholls, S.J., Tuzcu, E.M., Wolski, K., et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol 49 (2007), 263–270.
111. 111 Kataoka, Y., Wolski, K., Uno, K., et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol 59 (2012), 1592–1597.
112. 112 Otsuka, F., Finn, A.V., Virmani, R., Do vulnerable and ruptured plaques hide in heavily calcified arteries?. Atherosclerosis 229 (2013), 34–37.
113. 113 Mauriello, A., Servadei, F., Zoccai, G.B., et al. Coronary calcification identifies the vulnerable patient rather than the vulnerable plaque. Atherosclerosis 229 (2013), 124–129.
114. 114 Criqui, M.H., Denenberg, J.O., Ix, J.H., et al. Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 311 (2014), 271–278.
115. 115 Gössl, M., Versari, D., Hildebrandt, H.A., et al. Segmental heterogeneity of vasa vasorum neovascularization in human coronary atherosclerosis. J Am Coll Cardiol Img 3 (2010), 32–40.
116. 116 Callister, T.Q., Raggi, P., Cooil, B., et al. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med 339 (1998), 1972–1978.
117. 117 Achenbach, S., Ropers, D., Pohle, K., et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 106 (2002), 1077–1082.
118. 118 Arad, Y., Spadaro, L.A., Roth, M., et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. J Am Coll Cardiol 46 (2005), 166–172.
119. 119 Puri, R., Nicholls, S.J., Shao, M., et al. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol 65 (2015), 1273–1282.
120. 120 Shaw, L.J., Narula, J., Chandrashekhar, Y., The never-ending story on coronary calcium: is it predictive, punitive, or protective?. J Am Coll Cardiol 65 (2015), 1283–1285.
121. 121 Kolodgie, F.D., Burke, A.P., Farb, A., et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 16 (2001), 285–292.
122. 122 Maldonado, N., Kelly-Arnold, A., Vengrenyuk, Y., et al. A mechanistic analysis of the role of microcalcifications in atherosclerotic plaque stability: potential implications for plaque rupture. Am J Physiol Heart Circ Physiol 303 (2012), H619–H628.
123. 123 Cardoso, L., Kelly-Arnold, A., Maldonado, N., et al. Effect of tissue properties, shape and orientation of microcalcifications on vulnerable cap stability using different hyperelastic constitutive models. J Biomech 47 (2014), 870–877.
124. 124 Cheng, G.C., Loree, H.M., Kamm, R.D., et al. Distribution of circumferential stress in ruptured and stable atherosclerotic lesions. A structural analysis with histopathological correlation. Circulation 87 (1993), 1179–1187.
125. 125 Cilla, M., Pena, E., Martinez, M.A., 3D computational parametric analysis of eccentric atheroma plaque: influence of axial and circumferential residual stresses. Biomech Model Mechanobiol 11 (2012), 1001–1013.
126. 126 Ruiz, J.L., Hutcheson, J.D., Aikawa, E., Cardiovascular calcification: current controversies and novel concepts. Cardiovasc Pathol 24 (2015), 207–212.
127. 127 Okura, H., Taguchi, H., Kubo, T., et al. Atherosclerotic plaque with ultrasonic attenuation affects coronary reflow and infarct size in patients with acute coronary syndrome: an intravascular ultrasound study. Circ J 71 (2007), 648–653.
128. 128 Kimura, S., Kakuta, T., Yonetsu, T., et al. Clinical significance of echo signal attenuation on intravascular ultrasound in patients with coronary artery disease. Circ Cardiovasc Interv 2 (2009), 444–454.
129. 129 Derlin, T., Richter, U., Bannas, P., et al. Feasibility of 18F-sodium fluoride PET/CT for imaging of atherosclerotic plaque. J Nucl Med 51 (2010), 862–865.
130. 130 Derlin, T., Wisotzki, C., Richter, U., et al. In vivo imaging of mineral deposition in carotid plaque using 18F-sodium fluoride PET/CT: correlation with atherogenic risk factors. J Nucl Med 52 (2011), 362–368.
131. 131 Derlin, T., Toth, Z., Papp, L., et al. Correlation of inflammation assessed by 18F-FDG PET, active mineral deposition assessed by 18F-fluoride PET, and vascular calcification in atherosclerotic plaque: a dual-tracer PET/CT study. J Nucl Med 52 (2011), 1020–1027.
132. 132 Blau, M., Nagler, W., Bender, M.A., Fluorine-18: a new isotope for bone scanning. J Nucl Med 3 (1962), 332–334.
133. 133 Blau, M., Ganatra, R., Bender, M.A., 18 F-fluoride for bone imaging. Sem Nucl Med 2 (1972), 31–37.
134. 134 Irkle, A., Vesey, A.T., Lewis, D.Y., et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun, 6, 2015, 7495.
135. 135 Gasser P, Voegel JC, Gramain Ph. Surface reactions on hydroxyapatite in the presence of fluoride ions 1. Saturated and congruent conditions. Colloids and Surfaces A: Physicochemical and Engineering Aspects 1993;74:275–86.
136. 136 Dweck, M.R., Chow, M.W., Joshi, N.V., et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 59 (2012), 1539–1548.
137. 137 Joshi, N.V., Vesey, A.T., Williams, M.C., et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 383 (2014), 705–713.